Advisory boards typically assemble a group of Key Opinion Leaders (KOLs) or top Principal Investigators (PIs), who can anticipate your future environment and validate your long-term strategy.
Key business objectives
- Envision disease management evolution given the current treatments and future pipeline therapies
- Anticipate the potential uptake of new therapies, new MoA or novel technologies, and their impact on your future competitive environment
- Determine and prioritize the expected patient outcomes that would best leverage your clinical value
- Reveal the universe of opportunities in specific disease areas today and in the future